Can Quality-Adjusted Life-Years and Subgroups Help Us Decide Whether to Treat Late-Arriving Stroke Patients With Tissue Plasminogen Activator? - 20/12/12
, Emmett Keeler, PhDSupervising editors: David L. Schriger, MD, MPH; Donald M. Yealy, MD
Le texte complet de cet article est disponible en PDF.| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. |
|
| Publication date: Available online July 27, 2012. |
|
| A podcast for this article is available at www.annemergmed.com. |
Vol 61 - N° 1
P. 56-57 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
